Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Publications (10 of 39) Show all publications
Kabashkin, I., Krainukovs, A., Pasicniks, D., Gercevs, I., Gerceva, V., Muhins, E., . . . Petrovs, V. (2026). An Intelligent Differential Capacitive Bioelectronic Sensing System for Reliable Microfluidic Reagent Delivery in Automated Pathology. Electronics, 15(10), Article ID 2101.
Open this publication in new window or tab >>An Intelligent Differential Capacitive Bioelectronic Sensing System for Reliable Microfluidic Reagent Delivery in Automated Pathology
Show others...
2026 (English)In: Electronics, E-ISSN 2079-9292, Vol. 15, no 10, article id 2101Article in journal (Refereed) Published
Abstract [en]

This article presents an intelligent differential capacitive bioelectronic sensing system that provides an experimental foundation for future AI-assisted reliable microfluidic reagent delivery in automated pathology. The proposed platform integrates a slot-type microfluidic chamber, a differential slot-line capacitive sensor, embedded readout and signal-conditioning electronics, and a supervisory state assessment concept within a unified architecture. Its purpose is to support stable microliter-scale reagent exchange together with non-invasive process observability in automated staining workflows. The experimental study included flow calibration, analysis of feed direction and chamber tilt angle, preliminary vibration-assisted bubble mobilization, and evaluation of the sensing subsystem. The results showed that reliable operation is achieved only within a practically admissible regime in which fluidic stability and sensing informativeness overlap. In the investigated setup, upper-feed delivery and low chamber tilt angles provided the most favorable filling conditions, while the differential capacitive subsystem enabled stable detection of liquid-state changes in narrow microtubes. The reported results establish a foundation for future AI-assisted transport-state recognition and adaptive monitoring in automated pathology platforms.

Place, publisher, year, edition, pages
MDPI, 2026
Keywords
automated pathology, microfluidic reagent delivery, capacitive sensing, differential sensor, bioelectronic system, AI-assisted monitoring, immunohistochemistry
National Category
Medical Instrumentation
Identifiers
urn:nbn:se:uu:diva-588673 (URN)10.3390/electronics15102101 (DOI)001774411600001 ()2-s2.0-105040098402 (Scopus ID)
Available from: 2026-06-08 Created: 2026-06-08 Last updated: 2026-06-08Bibliographically approved
Kabashkin, I., Krainukovs, A., Pasicniks, D., Gercevs, I., Gerceva, V., Muhins, E., . . . Petrovs, V. (2026). Design of a Modular Cyber-Physical Architecture for Multiplex Histological Staining. Applied Sciences, 16(9), Article ID 4247.
Open this publication in new window or tab >>Design of a Modular Cyber-Physical Architecture for Multiplex Histological Staining
Show others...
2026 (English)In: Applied Sciences, E-ISSN 2076-3417, Vol. 16, no 9, article id 4247Article in journal (Refereed) Published
Abstract [en]

Automated multiplex immunohistochemistry (IHC) and in situ hybridization (ISH) require staining platforms that combine stable reagent exchange, low-volume operation, process observability, and protocol flexibility. Existing autostainers are often rigid and costly, whereas microfluidic and sensing solutions remain largely component-specific rather than system-oriented. This study proposes and partially validates a layered cyber-physical architecture for multiplex histological staining. The architecture integrates five functional layers-biochemical workflow, fluidic processing, capacitive sensing, protocol-driven control, and software-based process representation-within a unified formal framework and is supported at the subsystem level by experimental characterization of its fluidic and sensing layers. Fluidic experiments on a slot-type microfluidic chamber identified a practical operating window in which upper-feed operation, moderate calibrated flow conditions, and low chamber angles between 10 degrees and 40 degrees provide stable filling and acceptable drainage. The differential slot-line capacitive sensing subsystem detected liquid volumes as low as 0.5 & micro;L, with stable threshold-based interpretation at a practical detection threshold of approximately 5 fF after digital filtering. The control and software layers are specified at the architectural and formal model level; their hardware implementation and closed-loop validation remain subjects of future work. Together, the reported results demonstrate that controlled reagent transport and sensing-based process observability are jointly feasible within the proposed modular framework, establishing a conceptual and experimental foundation for scalable, flexible, and resource-efficient multiplex IHC/ISH systems.

Place, publisher, year, edition, pages
MDPI, 2026
Keywords
multiplex immunohistochemistry, in situ hybridization, cyber-physical system, layered architecture, microfluidic staining chamber, capacitive liquid sensing, laboratory automation
National Category
Materials Chemistry Immunology
Identifiers
urn:nbn:se:uu:diva-586630 (URN)10.3390/app16094247 (DOI)001763223600001 ()
Available from: 2026-05-22 Created: 2026-05-22 Last updated: 2026-05-22Bibliographically approved
Norum, J. H., Schandiz, H., Sauer, T., Geisler, J., Farkas, L., Hekmati, N., . . . Sørlie, T. (2026). Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situ. Scientific Reports, 16, Article ID 30274.
Open this publication in new window or tab >>Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situ
Show others...
2026 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 16, article id 30274Article in journal (Refereed) Published
Abstract [en]

Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive breast cancer, and up to 50% of the lesions remain non-invasive even if untreated. Both tumor and microenvironmental features are associated with disease progression, but the cellular interactions are poorly understood. We investigated DCIS of the clinical breast cancer subtypes; Triple Negative (TN) and Luminal A (LumA)-like, presumed to represent lesions with the most contrasting invasive potential, using spatial transcriptomic and multiplex immunofluorescence analyses. In the intraductal cancer cells, we found significant differences between the two subtypes in expression of genes related to energy metabolism and secreted proteins. In the periductal space, we found differences in the absolute density of CD4+ T cells, CD8+ T cells, and B cells between TN and LumA-like DCIS. Spatial cellular neighborhood analyses revealed an inverse relationship between CD4+ T cells and B cells. These data suggest specific biological properties of TN and LumA-like DCIS that might underpin differences in progression potential.

Place, publisher, year, edition, pages
Springer Nature, 2026
National Category
Cancer and Oncology Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-601969 (URN)10.1038/s41598-026-60008-9 (DOI)001889897800018 ()42386958 (PubMedID)2-s2.0-105052630422 (Scopus ID)
Available from: 2026-10-21 Created: 2026-10-21 Last updated: 2026-10-21Bibliographically approved
Lindberg, A., Hellberg, L., Grandon, A., Yu, H., Thurfjell, V., Wåhlén, E., . . . Strell, C. (2026). In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLC. Cell Communication and Signaling, 24, Article ID 55.
Open this publication in new window or tab >>In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLC
Show others...
2026 (English)In: Cell Communication and Signaling, E-ISSN 1478-811X, Vol. 24, article id 55Article in journal (Refereed) Published
Abstract [en]

Background: Increased stromal Platelet-derived growth factor receptor beta (PDGFRβ) expression is a hallmark of the desmoplastic tissue reaction in cancer and marks subsets of cancer-associated fibroblasts, pericytes, and smooth muscle cells. However, its functional status in situ has been anticipated from static expression measures, which cannot determine whether high receptor abundance reflects active signaling.

Methods: We established two second-generation proximity ligation assays (PLAs) to quantify PDGFRβ activation in the in situ environment of human lung cancer by detecting either phosphorylated PDGFRβ or its interaction with the adaptor protein Grb2. The immunofluorescence-based assays were applied to tissue-microarrays including diagnostic samples from over 600 non-small cell lung cancer (NSCLC) patients.

Results: In lung cancer tissue, activation scores correlated with PDGFRβ expression but revealed a more nuanced receptor status, indicating variable activation despite similar expression levels. Higher PDGFRβ activation was associated with increased recurrence risk exclusively in squamous cell carcinoma, a finding not captured by conventional immunohistochemistry. This activation was accompanied by a specific stromal profile enriched for LRRC15- and FAP-positive cells, a pattern absent in adenocarcinomas.

Conclusion: PDGFRβ activation status provides functional information beyond receptor expression, uncovering clinically relevant, otherwise overlooked, stromal phenotypes. The approach illustrates the diagnostic potential of functional protein assays in the era of precision medicine.

Place, publisher, year, edition, pages
Springer Nature, 2026
National Category
Cancer and Oncology Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-578638 (URN)10.1186/s12964-026-02651-3 (DOI)001674078200001 ()41540507 (PubMedID)2-s2.0-105028893909 (Scopus ID)
Funder
Uppsala UniversitySwedish Cancer SocietySwedish Research CouncilSjöberg Foundation
Available from: 2026-02-06 Created: 2026-02-06 Last updated: 2026-02-06Bibliographically approved
Marwitz, S., Brunnstrom, H., Gulyas, M., Botling, J., Reck, M., Kugler, C., . . . Goldmann, T. (2026). Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival. European Journal of Cancer, 244, Article ID 116868.
Open this publication in new window or tab >>Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival
Show others...
2026 (English)In: European Journal of Cancer, ISSN 0959-8049, E-ISSN 1879-0852, Vol. 244, article id 116868Article in journal (Refereed) Published
Abstract [en]

Background: Non-small cell lung cancer (NSCLC) is a heterogenous disease with challenging prognosis despite clinical improvements in the last years. The tumor-microenvironment (TME) is a major factor with many cell types involved as well as distinct spatial organization. We assessed the global immune landscape and spatial architecture of excluded immune cell types within the stroma of NSCLC tissues.

Methods: Multiplex Immunofluorescence (mIF) staining was used to detect major immune cell lineages in tissues of 674 NSCLC patients. AI-based digital image analyses were conducted to stratify NSCLC tissues into stroma and tumor compartments as well as identify and classify single cells based on mIF marker combinations into major immune cell phenotypes. Quantitative single-cell resolved immune cell phenotypes within the stroma area were used to cluster patients based on their excluded immune signature and spatial architecture and explored for impact on overall-survival.

Results: NSCLC stroma harbored distinct immune cell as well as spatial organizational patterns with varying combinations. Among these, a mixed immune landscape together with a stromal organization dominated by long distances to B cells and short distances to Helper T cells was associated with long-term overall-survival. This was successfully reduced to a two-variable signature comprising three different cell types, where short distances of Helper T cells to Regulatory T cells in conjunction with high B cell densities provided superior prognostic value.

Conclusions: The excluded immune cells within the stromal compartment are associated with strong prognostic effects based on their spatial architecture and represent a previously underappreciated cell population.

Place, publisher, year, edition, pages
Elsevier, 2026
Keywords
NSCLC, Stroma, Diversity, Spatial biology, Tumor microenvironment
National Category
Cancer and Oncology Cell and Molecular Biology Clinical Laboratory Medicine
Identifiers
urn:nbn:se:uu:diva-594416 (URN)10.1016/j.ejca.2026.116868 (DOI)001812936400001 ()42372636 (PubMedID)2-s2.0-105042855972 (Scopus ID)
Available from: 2026-07-27 Created: 2026-07-27 Last updated: 2026-07-27Bibliographically approved
Magoulopoulou, A., Chatzinikolaou, M., Metousis, A., Hu, T., Yu, H., Zerdes, I., . . . Nilsson, M. (2026). Spatially resolved T cell receptor diversity mapping uncovers of the cancer immune microenvironment. eBioMedicine, 127, Article ID 106264.
Open this publication in new window or tab >>Spatially resolved T cell receptor diversity mapping uncovers of the cancer immune microenvironment
Show others...
2026 (English)In: eBioMedicine, E-ISSN 2352-3964, Vol. 127, article id 106264Article in journal (Refereed) Published
Abstract [en]

Background

T cell receptor (TCR) binding properties have been related to a wide range of pathological conditions, including infections, autoimmunity and cancer. Characterising the TCR repertoire is of great biomedical interest but it has been challenging due to its high structural diversity.

Methods

In situ sequencing (ISS) is a suitable technique for spatial cell typing and linking gene patterns directly to specific histopathological features of large biopsy areas. We applied ISS through the commercial Xenium platform, with the addition of a custom panel specifically designed for TCR gene detection. Based on the IMGT database, we selected unique target sequences for TCR genes encoding the constant, variable and joining TCR chains. Additionally, we developed an analysis pipeline for the assignment of putative clonotypes based on simultaneous expression of alpha and beta variable TCR chains (TCRV beta/V alpha pairs) at the single-cell level.

Findings

Our approach captured specific immune cell distributions in relation to the individual sample clonality, as well as regional dominance of certain TCRV beta/V alpha pairs in surgical non-small cell lung cancer (NSCLC) specimens and matching lymph node samples. Furthermore, we were able to study the spatiotemporal evolution of TCR repertoire on longitudinal FFPE biopsies from patients with breast cancer, during neoadjuvant treatment. Interpretation This study highlights the implementation of target-based spatially resolved transcriptomics for the spatial characterisation of TCRV beta/V alpha pairs at the single-cell level, without the need for prior sequencing. Our approach allows for spatial immune characterisation of diagnostic tissue samples with emphasis on T cell biology and accompanying T cell diversity.

Place, publisher, year, edition, pages
Elsevier, 2026
Keywords
In situ sequencing (ISS), T cell receptor (TCR), Non-small cell lung cancer (NSCLC), Spatially resolved transcriptomics (SRT), TCR diversity, Breast cancer
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-586532 (URN)10.1016/j.ebiom.2026.106264 (DOI)001756710500001 ()42034048 (PubMedID)2-s2.0-105036843929 (Scopus ID)
Funder
Swedish Cancer Society, CAN 2021/1726Swedish Research Council, 2019-01238Swedish Research Council
Available from: 2026-05-25 Created: 2026-05-25 Last updated: 2026-06-09Bibliographically approved
Nwadozi, E., Strell, C., Nordling, S., Lindberg, A., Backman, M., Daller Cosmen, P., . . . Claesson-Welsh, L. (2026). Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy. Cancer Letters, 658, Article ID 218728.
Open this publication in new window or tab >>Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy
Show others...
2026 (English)In: Cancer Letters, ISSN 0304-3835, E-ISSN 1872-7980, Vol. 658, article id 218728Article in journal (Refereed) Published
Abstract [en]

Leaky blood vessels are a hallmark of solid tumors. However, the molecular mechanisms and clinical implications of vascular leakage in human cancer remain unexplored. Here, we identified fibrinopeptide-A (FpA) as a robust in-situ marker of vascular leakage, analyzing diagnostic specimens from two non-small cell lung cancer (NSCLC) cohorts (N = 327 and N = 200). Mechanistically, FpA+ staining localized to discrete stromal niches characterized by increased endothelial VEGF receptor-2 phosphorylation, elevated VEGFA production by tumor cells and loss of the endothelial tyrosine phosphatase PTPRB. Immune profiling revealed reduced density of mature dendritic cells and granzyme B-expressing cytotoxic T cells in tumors with high-leakage. This leakage-associated immunosuppression was linked to the presence of tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD). However, compared to low-leakage, TLS in high-leakage tumors were enriched in regulatory T cells and conferred no survival advantage. Patients with high vascular leakage exhibited a reduced overall survival. Moreover, in a separate immunotherapy cohort (N = 64), high-leakage was associated with poor response to anti-PD-1/PD-L1 treatment. This study establishes vascular leakage as an important prognostic factor in NSCLC, and provides mechanistic understanding and a methodological framework to stratify NSCLC patients with regard to responsiveness to immunotherapy.

Place, publisher, year, edition, pages
Elsevier, 2026
Keywords
Non-small cell lung cancer, Vascular leakage, Fibrinopeptide A, VEPTP, Tertiary lymphoid structures, Immunotherapy response
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-595809 (URN)10.1016/j.canlet.2026.218728 (DOI)001839903800001 ()42486347 (PubMedID)2-s2.0-105046045859 (Scopus ID)
Funder
Swedish Cancer Society, 25 4398 Pj 01 HSwedish Cancer Society, 21-1790Swedish Cancer Society, 211749PjSwedish Research Council, 2025-02853Swedish Research Council, 2022-01151Knut and Alice Wallenberg Foundation, KAW 2023.0212
Note

De två sista författarna delar sistaförfattarskapet

Available from: 2026-08-19 Created: 2026-08-19 Last updated: 2026-08-19Bibliographically approved
Pietilä, R., Genové, G., Mocci, G., Miao, Y., Liu, J., Leptidis, S., . . . Muhl, L. (2025). A comprehensive molecular atlas of the mesenchymal cell types in the mouse liver. EMBO Reports, 26(21), 5326-5359
Open this publication in new window or tab >>A comprehensive molecular atlas of the mesenchymal cell types in the mouse liver
Show others...
2025 (English)In: EMBO Reports, ISSN 1469-221X, E-ISSN 1469-3178, Vol. 26, no 21, p. 5326-5359Article in journal (Refereed) Published
Abstract [en]

The liver plays crucial roles in many essential physiological processes, and its impaired function due to liver fibrosis from various causes is an increasingly significant health issue. The liver's functionality relies on the precise arrangement of its cellular structures, yet the molecular architecture of these units remains only partially understood. We created a comprehensive molecular atlas detailing the major cell types present in the adult mouse liver through deep single-cell RNA sequencing. Our analysis offers new insights into hepatic endothelial and mesenchymal cells, specifically highlighting the diversity of cells in the periportal microvasculature, the sinusoids, and the portal vein, the latter exhibiting a mixed arterio-venous phenotype. We identified distinct subpopulations of hepatic stellate cells, fibroblasts, and vascular mural cells located in different anatomical liver regions. Comparisons with transcriptomic data from disease models indicate that a previously unrecognized capsular population of hepatic stellate cells expands in response to fibrotic disease. Our findings reveal that various fibroblast subpopulations respond differently to pathological insults. This data resource will be relevant for the advancement of therapies targeting hepatic diseases.

Place, publisher, year, edition, pages
Springer Nature, 2025
Keywords
Hepatic Stellate Cells (HSC), Liver Cell Transcriptomes, Liver Mesenchymal Cell Heterogeneity, Peribiliary Vasculature, Single-cell RNA-sequencing (scRNA-seq)
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-583324 (URN)10.1038/s44319-025-00580-9 (DOI)001571209400001 ()40954217 (PubMedID)2-s2.0-105016253260 (Scopus ID)
Available from: 2026-03-27 Created: 2026-03-27 Last updated: 2026-03-31Bibliographically approved
Söderqvist, S., Viljamaa, A., Geyer, N., Keller, A.-L., Ruksha, K., Strell, C., . . . Gerling, M. (2025). An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer. Nature Communications, 16, Article ID 8307.
Open this publication in new window or tab >>An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer
Show others...
2025 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 16, article id 8307Article in journal (Refereed) Published
Abstract [en]

Pancreatic cancer is an aggressive disease with a dense fibrotic stroma and is often accompanied by chronic inflammation. Peritumoral inflammation is typically viewed as a reaction to nearby tumor growth. Here, we report that the inflamed pancreatic lobules are frequently invaded by tumor cells, forming a distinct, non-fibrotic tumor niche. Using a semi-supervised machine learning approach for annotations of clinical samples and multiplex protein profiling, we show that tumor cells at the invasion front are closely associated with acinar cells undergoing damage-induced changes, and with activated fibroblasts expressing markers of injury. The invaded lobules are linked to classical tumor phenotypes, in contrast to fibrotic areas where tumor cells display a more basal profile, highlighting microenvironment-dependent tumor subtype differences. In female mice, lobular invasion similarly aligns with the classical tumor phenotype. Together, our data reveal that pancreatic tumors colonize injured lobules, creating a unique niche that shapes tumor characteristics and contributes to disease biology.

Place, publisher, year, edition, pages
Springer Nature, 2025
National Category
Cancer and Oncology Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-569962 (URN)10.1038/s41467-025-63864-7 (DOI)001582507700006 ()41006303 (PubMedID)2-s2.0-105017414928 (Scopus ID)
Funder
Karolinska InstituteSwedish Research Council, 2018-02023Swedish Research Council, 2024-03026Swedish Cancer Society, 22 2175 PjSwedish Cancer Society, 23 2856 PjRegion StockholmSwedish National Infrastructure for Computing (SNIC)Swedish Society for Medical Research (SSMF), PD21-0114The Cancer Research Funds of RadiumhemmetBengt Ihres FoundationRuth and Richard Julin Foundation
Available from: 2025-10-20 Created: 2025-10-20 Last updated: 2025-10-20Bibliographically approved
Lindberg, A., Muhl, L., Yu, H., Hellberg, L., Artursson, R., Friedrich, J., . . . Strell, C. (2025). In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC. Journal of Thoracic Oncology, 20(5), 625-640
Open this publication in new window or tab >>In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC
Show others...
2025 (English)In: Journal of Thoracic Oncology, ISSN 1556-0864, E-ISSN 1556-1380, Vol. 20, no 5, p. 625-640Article in journal (Refereed) Published
Abstract [en]

Background

Immune checkpoint inhibitors (ICIs) have transformed lung cancer treatment, yet their effectiveness appears restricted to certain patient subsets. Current clinical stratification based on PD-L1 expression offers limited predictive value. Given the mechanism of action, directly detecting spatial PD1–PD-L1 interactions might yield more precise insights into immune responses and treatment outcomes.

Methods

We applied a second-generation in situ proximity ligation assay (PLA) to detect PD1–PD-L1 interactions in diagnostic tissue samples from 16 different cancer types, a tissue microarray from 352 surgically resected early-stage non-small cell lung cancer (NSCLC) patients, and finally diagnostic biopsies from 242 advanced NSCLC patients with and without ICI treatment. RNAseq analysis was used to identify potential resistance mechanisms.

Results

In the early-stage NSCLC, only about half of the cases with detectable PD-L1 and PD1 expression showed PD1–PD-L1 interactions, with significantly lower levels in EGFR-mutated tumors. Interaction levels varied across cancer types, aligning with reported ICI response rates. In ICI-treated NSCLC patients, higher PD1–PD-L1 interactions were linked to complete responses and longer survival, outperforming standard PD-L1 expression assays. Patients who, despite high PD1–PD-L1 interactions, did not respond to ICIs, showed additional expression of stromal immune mediators (EOMES, HAVCR1/TIM-1, JAML, FCRL1).

Conclusion

Our study proposes a diagnostic shift from static biomarker quantification to assessing active immune pathways, providing more precise ICI treatment. This functional concept applies to tiny lung biopsies and can be used to further immune checkpoints. Accordingly, our results indicate concerted ICI resistance mechanisms, highlighting a need for combination diagnostics and therapies.

Place, publisher, year, edition, pages
Elsevier, 2025
Keywords
Immune checkpoint inhibitor (ICI), Programmed death-ligand 1 (PD-L1), Programmed cell death protein 1 (PD1), non-small cell lung cancer (NSCLC), Proximity ligation assay (PLA)
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-546466 (URN)10.1016/j.jtho.2024.12.026 (DOI)001504694800008 ()39743139 (PubMedID)2-s2.0-85216903906 (Scopus ID)
Funder
Swedish Research Council, 2022-01151Sjöberg FoundationSwedish Cancer Society, 21149PJSwedish Cancer Society, 211790PJSwedish Research Council, 2021-02693Insamlingsstiftelsen Lions Cancerforskningsfond Mellansverige Uppsala-ÖrebroSwedish Cancer Society, 201368PjDr. Margaretha Nilssons Stiftelse för Medicinsk forskning
Note

Patrick Micke och Carina Strell delar sistaförfattarskapet

Available from: 2025-01-09 Created: 2025-01-09 Last updated: 2026-11-06Bibliographically approved
Projects
TGF-beta signaling as a determinant of stroma remodeling and immune response in lung cancer [2021-02693_VR]; Uppsala University; Publications
Lindberg, A., Muhl, L., Yu, H., Hellberg, L., Artursson, R., Friedrich, J., . . . Strell, C. (2025). In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC. Journal of Thoracic Oncology, 20(5), 625-640
EvoMaps: How cellular ecosystems drive early breast cancer evolution [2022-01151_VR]; Uppsala University; Publications
Nwadozi, E., Strell, C., Nordling, S., Lindberg, A., Backman, M., Daller Cosmen, P., . . . Claesson-Welsh, L. (2026). Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy. Cancer Letters, 658, Article ID 218728. Lindberg, A., Muhl, L., Yu, H., Hellberg, L., Artursson, R., Friedrich, J., . . . Strell, C. (2025). In situ detection of PD1–PD-L1 interactions as a functional predictor for response to immune checkpoint inhibition in NSCLC. Journal of Thoracic Oncology, 20(5), 625-640He, L., Testini, C., Hekmati, N., Bonello, A., Schiza, A., Nwadozi, E., . . . Welsh, M. (2025). Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity. Molecular Oncology, 20(3)
In situ identification of the active immune regulatory mechanism of resistance: A functional concept for precision diagnostics in lung cancer [2025-02758_VR]; Uppsala University
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-3783-7256

Search in DiVA

Show all publications